Dr. Josep Redón i Mas

Principal Investigator
Research Group on the Study of Cardiometabolic and Renal Risk

Presentation

Principal
Investigator
Dr. Josep Redón i Mas

josep.redon@uv.es; jredon@uv.es

Publications
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). Mancia Chairperson G, Kreutz Co-Chair R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, Muiesan M, Tsioufis K, Agabiti-Rosei E, Algharably E, Azizi M, Benetos A, Borghi C, Hitij J, Cifkova R, Coca A, Cornelissen V, Cruickshank K, Cunha P, Danser A, de Pinho R, Delles C, Dominiczak A, Dorobantu M, Doumas M, Fernandez-Alfonso M, Halimi J, Jarai Z, Jelakovic B, Jordan J, Kuznetsova T, Laurent S, Lovic D, Lurbe E, Mahfoud F, Manolis A, Miglinas M, Narkiewicz K, Niiranen T, Palatini P, Parati G, Pathak A, Persu A, Polonia J, Redon J, Sarafidis P, Schmieder R, Spronck B, Stabouli S, Stergiou G, Taddei S, Thomopoulos C, Tomaszewski M, Van de Borne P, Wanner C, Weber T, Williams B, Zhang Z, Kjeldsen S. Journal of Hypertension. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. PMID: 37345492

Association of single and joint metals with albuminuria and estimated glomerular filtration longitudinal change in middle-aged adults from Spain: The Aragon workers health study. Grau-Perez M, Domingo-Relloso A, Garcia-Barrera T, Gomez-Ariza J, Leon-Latre M, Casasnovas J, Moreno-Franco B, Laclaustra M, Guallar E, Navas-Acien A, Pastor-Barriuso R, Redon J, Tellez-Plaza M. Environmental Pollution. 2023 Feb 1;318:120851. doi: 10.1016/j.envpol.2022.120851. PMID: 36509352

Cardiovascular risk of metabolically healthy obesity in two european populations: prevention potential from a metabolomic study. Wei D, Gonzalez-Marrachelli V, Melgarejo J, Liao C, Hu A, Janssens S, Verhamme P, Van Aelst L, Vanassche T, Redon J, Tellez-Plaza M, Martin-Escudero J, Monleon D, Zhang Z. Cardiovascular Diabetology. 2023 Apr 7;22(1):82. doi: 10.1186/s12933-023-01815-6. PMID: 37029406

Comparison of GLP-1 Receptor agonists and other glucose-lowering agents on cardiovascular outcomes in individuals with type 2 diabetes and obesity: a spanish real-world population-based study. Palanca A, Javier Ampudia-Blasco F, Miguel Calderon J, Sauri I, Martinez-Hervas S, Luis Trillo J, Redon J, Real J. Diabetes Research and Clinical Practice. 2023 Dec 22:111071. doi: 10.1016/j.diabres.2023.111071. PMID: 38142748

Corrigendum to Genetic interaction in the association between oxidative stress and diabetes in the Spanish population [Free Radic. Biol. Med. 205 (2023) 62-68]. Melero R, Quiroz-Rodríguez ME, Lara-Hernández F, Redón J, Sáez G, Briongos-Figuero LS, Abadía-Otero J, Martín-Escudero JC, Chaves FJ, Ayala G, García-García AB. Free Radical Biology & Medicine. 2023 Jul 22;207:181-182. doi: 10.1016/j.freeradbiomed.2023.07.017. PMID: 37487450

Diminishing benefits of urban living for children and adolescents’ growth and development. NCD Risk Factor Collaboration (NCD-RisC). Nature. 2023 Mar;615(7954):874-883. doi: 10.1038/s41586-023-05772-8. PMID: 36991188

Genetic interaction in the association between oxidative stress and diabetes in the Spanish population. Melero R, Quiroz-Rodriguez M, Lara-Hernandez F, Redon J, Saez G, Briongos-Figuero L, Abadia-Otero J, Martin-Escudero J, Chaves F, Ayala G, Garcia-Garcia A. Free Radical Biology & Medicine. 2023 Jun 1;205:62-68. doi: 10.1016/j.freeradbiomed.2023.05.030. PMID: 37268047

Global variation in diabetes diagnosis and prevalence based on fasting glucose and hemoglobin A1c. NCD Risk Factor Collaboration (NCD-RisC). Nature Medicine. 2023 Nov;29(11):2885-2901. doi: 10.1038/s41591-023-02610-2. PMID: 37946056

High miR-126-3p levels associated with cardiovascular events in a general population. Martinez-Arroyo O, Ortega A, Flores-Chova A, Sanchez-Garcia B, Garcia-Garcia A, Chaves F, Martin-Escudero J, Forner M, Redon J, Cortes R. European Journal of Internal Medicine. 2023 Jul;113:49-56. doi: 10.1016/j.ejim.2023.04.013. PMID: 37080818

Impact of finerenone-induced albuminuria reduction on chronic kidney disease outcomes in type 2 Diabetes A mediation analysis. Agarwal R, Tu W, Farjat A, Fang Y, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope L, Rossing P, Pitt B, Filippatos G, Anker S, Bakris G. Annals of Internal Medicine. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. PMID: 38048573

Metabolomic patterns, redox-related genes and metals, and bone fragility endpoints in the Hortega Study. Galvez-Fernandez M, Rodriguez-Hernandez Z, Grau-Perez M, Chaves F, Garcia-Garcia A, Amigo N, Monleon D, Garcia-Barrera T, Gomez-Ariza J, Briongos-Figuero L, Perez-Castrillon J, Redon J, Tellez-Plaza M, Martin-Escudero J. Free Radical Biology & Medicine. 2023 Jan;194:52-61. doi: 10.1016/j.freeradbiomed.2022.11.007. PMID: 36370960

Persistence and determinants of blood pressure phenotypes according to office and ambulatory blood pressure measurements in youth. Martinez F, Redon J, Aguilar F, Calderon JM, Lurbe E. Hypertension Research. 2023 May;46(5):1257-1266. doi: 10.1038/s41440-022-01159-w. PMID: 36635525

Rab3A/Rab27A system silencing ameliorates high glucose-induced injury in podocytes. Martinez-Arroyo O, Flores-Chova A, Sanchez-Garcia B, Redon J, Cortes R, Ortega A. Biology-Basel. 2023 May 9;12(5):690. doi: 10.3390/biology12050690. PMID: 37237503

Real-world evaluation of GLP-1 receptor agonist therapy persistence, adherence and therapeutic inertia among obese adults with Type 2 Diabetes. Palanca A, Ampudia Blasco F, Calderon J, Sauri I, Martinez Hervas S, Trillo J, Redon J, Real J. Diabetes Therapy. 2023 Apr;14(4):723-736. doi: 10.1007/s13300-023-01382-9. PMID: 36847952

Single-Pill combination with three antihypertensive agents to improve blood pressure control in hypertension: focus on olmesartan-based combinations. Burnier M, Redon J, Volpe M. High Blood Pressure & Cardiovascular Prevention. 2023 Mar;30(2):109-121. doi: 10.1007/s40292-023-00563-8. PMID: 36696054

Towards a personalized health care using a divisive hierarchical clustering approach for comorbidity and the prediction of conditioned group risks. Navarro-Cerdán J, Sánchez-Gomis M, Pons P, Gálvez-Settier S, Valverde F, Ferrer-Albero A, Saurí I, Fernández A, Redon J. Health Informatics Journal. 2023 Oct-Dec;29(4):14604582231212494. doi: 10.1177/14604582231212494. PMID: 38072502

Traffic density exposure, oxidative stress biomarkers and plasma metabolomics in a population-based sample: the Hortega Study. Sanchez-Rodriguez L, Galvez-Fernandez M, Rojas-Benedicto A, Domingo-Relloso A, Amigo N, Redon J, Monleon D, Saez G, Tellez-Plaza M, Martin-Escudero J, Ramis R. Antioxidants. 2023 Dec 15;12(12):2122. doi: 10.3390/antiox12122122. PMID: 38136241

2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension. Gorostidi M, Gijón-Conde T, de la Sierra A, Rodilla E, Rubio E, Vinyoles E, Oliveras A, Santamaría R, Segura J, Molinero A, Pérez-Manchón D, Abad M, Abellán J, Armario P, Banegas JR, Camafort M, Catalina C, Coca A, Divisón JA, Domenech M, Martell N, Martín-Rioboó E, Morales-Olivas F, Pallarés V, Pérez de Isla L, Prieto MA, Redón J, Ruilope LM, García-Donaire JA. Hipertensión y Riesgo Vascular. 2022 Oct-Dec;39(4):174-194. doi: 10.1016/j.hipert.2022.09.002. PMID: 36153303

A comprehensive urban programme to reduce energy poverty and its effects on health and wellbeing of citizens in six European countries: study protocol of a controlled trial. Stevens M, Raat H, Ferrando M, Vallina B, Lucas R, Middlemiss L, Redon J, Rocher E, van Grieken A. BMC Public Health. 2022 Aug 19;22(1):1578. doi: 10.1186/s12889-022-13968-2. PMID: 35986259

Angiotensin receptor blockers evaluated by office and home blood pressure measurements. TeleHBPM Study. Barroso Weimar Kunz Sebba, Brandao AA, Valverde de Oliveira Vitorino P, Diogenes de Magalhaes Feitosa A, Costa Duarte Barbosa E, Dischinger Miranda R, Redon J, Camafort-Babkowski M, Coca A, Mota Gomes MA. Arquivos Brasileiros de Cardiologia. 2022 May 9;118(6):1069-1082. doi: 10.36660/abc.20210504. PMID: 35544853

Association between exercise frequency with renal and cardiovascular outcomes in diabetic and non-diabetic individuals at high cardiovascular risk. Bohm M, Schumacher H, Werner C, Teo K, Lonn E, Mahfoud F, Speer T, Mancia G, Redon J, Schmieder R, Sliwa K, Marx N, Weber M, Laufs U, Williams B, Yusuf S, Mann J. Cardiovascular Diabetology. 2022 Jan 20;21(1):12. doi: 10.1186/s12933-021-01429-w. PMID: 35057807

Biofluid specificity of long non-coding RNA profile in hypertension: relevance of exosomal fraction. Riffo-Campos AL, Perez-Hernandez J, Martinez-Arroyo O, Ortega A, Flores-Chova A, Redon J, Cortes R. International Journal of Molecular Sciences. 2022 May 6;23(9):5199. doi: 10.3390/ijms23095199. PMID: 35563588

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial. Schlaich MP, Bellet M, Weber MA, Danaietash P, Bakris GL, Flack JM, Dreier RF, Sassi-Sayadi M, Haskell LP, Narkiewicz K, Wang JG. Lancet. 2022 Dec 3;400(10367):1927-1937. doi: 10.1016/S0140-6736(22)02034-7. PMID: 36356632

Exosomal and plasma non-coding RNA signature associated with urinary albumin excretion in hypertension. Riffo-Campos A, Perez-Hernandez J, Ortega A, Martinez-Arroyo O, Flores-Chova A, Redon J, Cortes R. International Journal of Molecular Sciences. 2022 Jan 13;23(2):823. doi: 10.3390/ijms23020823. PMID: 35055008

Gene-environment interaction analysis of redox-related metals and genetic variants with plasma metabolic patterns in a general population from Spain: the Hortega Study. Galvez-Fernandez M, Sanchez-Saez F, Domingo-Relloso A, Rodriguez-Hernandez Z, Tarazona S, Gonzalez-Marrachelli V, Grau-Perez M, Morales-Tatay J, Amigo N, Garcia-Barrera T, Gomez-Ariza J, Chaves F, Garcia-Garcia A, Melero R, Tellez-Plaza M, Martin-Escudero J, Redon J, Monleon D. Redox Biology. 2022 Jun;52:102314. doi: 10.1016/j.redox.2022.102314. PMID: 35460952

Healthy lifestyle, metabolomics and incident type 2 diabetes in a population-based cohort from Spain. Delgado-Velandia M, Gonzalez-Marrachelli V, Domingo-Relloso A, Galvez-Fernandez M, Grau-Perez M, Olmedo P, Galan I, Rodriguez-Artalejo F, Amigo N, Briongos-Figuero L, Redon J, Martin-Escudero J, Monleon-Salvado D, Tellez-Plaza M, Sotos-Prieto M. International Journal of Behavioral Nutrition and Physical Activity. 2022 Jan 27;19(1):8. doi: 10.1186/s12966-021-01219-3. PMID: 35086546

High sensitivity troponins: a potential biomarkers of cardiovascular risk for primary prevention. Leite L, Matos P, Leon-Justel A, Espirito-Santo C, Rodriguez-Padial L, Rodrigues F, Orozco D, Redon J. Frontiers In Cardiovascular Medicine. 2022 Nov 30;9:1054959. doi: 10.3389/fcvm.2022.1054959. PMID: 36531726

Incidence and impact of atrial fibrillation in heart failure patients: real-world data in a large community. Diaz J, Martinez F, Calderon JM, Fernandez A, Sauri I, Uso R, Trillo JL, Redon J, Forner MJ. ESC Heart Failure. 2022 Dec;9(6):4230-4239. doi: 10.1002/ehf2.14124. PMID: 36111519

Insights from matched office and ambulatory blood pressure in youth: clinical relevance. Lurbe E, Redon J, Alvarez J, Grau-Perez M, Martinez F, Mancia G. Hypertension. 2022 Mar 29;101161HYPERTENSIONAHA12218993. doi: 10.1161/HYPERTENSIONAHA.122.18993. PMID: 35345885

Lipoprotein profiles of fat distribution and its association with insulin sensitivity. Wei D, Marrachelli V, Melgarejo J, Liao C, Janssens S, Verhamme P, Vanassche T, Van Aelst L, Monleon D, Redon J, Zhang Z. Frontiers in Endocrinology. 2022 Oct 25;13:978745. doi: 10.3389/fendo.2022.978745. PMID: 36387872

Narrative update of clinical trials with antihypertensive drugs in children and adolescents. Redon J, Seeman T, Pall D, Suurorg L, Kamperis K, Erdine S, Wuhl E, Mancia G. Frontiers In Cardiovascular Medicine. 2022 Nov 21;9:1042190. doi: 10.3389/fcvm.2022.1042190. PMID: 36479567

New insights of cardiovascular and renal protection in diabetic chronic kidney disease with finerenone. Redon J. Cardiovascular Research. 2022 Mar 25;118(5):e36-e37. doi: 10.1093/cvr/cvac024. PMID: 35333317

Real world data of anticoagulant treatment in non-valvular atrial fibrillation across renal function status. Calderon J, Martinez F, Fernandez A, Sauri I, Diaz J, Uso R, Trillo J, Redon J, Forner M. Scientific reports. 2022 Apr 12;12(1):6123. doi: 10.1038/s41598-022-10164-5. PMID: 35414001

Real-world data of anticoagulant treatment in non-valvular atrial fibrillation. Calderon J, Martinez F, Diaz J, Fernandez A, Sauri I, Uso R, Trillo J, Vela S, Bea C, Redon J, Forner M. Frontiers In Cardiovascular Medicine. 2022 Jan 21;8:733300. doi: 10.3389/fcvm.2021.733300. PMID: 35127843

Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients. Olea B, Albert E, Torres I, Amat P, Remigia M, Gozalbo-Rovira R, Rodriguez-Diaz J, Buesa J, Blasco M, Redon J, Signes-Costa J, Navarro D. Journal of Clinical Virology. 2021 Sep;142:104943. doi: 10.1016/j.jcv.2021.104943. PMID: 34391981

Analysis of LDL and HDL size and number by nuclear magnetic resonance in a healthy working population: the LipoLab Study.. Pallares-Carratala V, Quesada J, Orozco-Beltran D, Amigo-Grau N, Lopez-Pineda A, Fernandez Gimenez A, Gil-Guillen V, Correig X, Masana L, Monleon Salvado D, Redón Mas J, Pascual R, Carratala-Munuera C. International Journal of Clinical Practice. 2021 Jan;75(1):e13610. doi: 10.1111/ijcp.13610. PMID: 32648987

Anthropometric indicators as a tool for diagnosis of obesity and other health risk factors: a literature review. Piqueras P, Ballester A, Dura-Gil J, Martinez-Hervas S, Redon J, Real J. Frontiers in Psychology. 2021 Jul 9;12:631179. doi: 10.3389/fpsyg.2021.631179. PMID: 34305707

Arsenic, cadmium, and selenium exposures and bone mineral density-related endpoints: The Hortega study. Galvez-Fernandez M, Grau-Perez M, Garcia-Barrera T, Ramirez-Acosta S, Gomez-Ariza J, Perez-Gomez B, Galan-Labaca I, Navas-Acien A, Redon J, Briongos-Figuero L, Duenas-Laita A, Perez-Castrillon J, Tellez-Plaza M, Martin-Escudero J. Free Radical Biology & Medicine. 2021 Jan;162:392-400. doi: 10.1016/j.freeradbiomed.2020.10.318. PMID: 33137469

Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM, FIGARO-DKD Investigators. New England Journal of Medicine. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. PMID: 34449181

Cardiovascular outcomes in patients at high cardiovascular risk with previous myocardial infarction or stroke. Boehm M, Schumacher H, Teo KK, Lonn EM, Lauder L, Mancia G, Redon J, Schmieder RE, Sliwa K, Marx N, Weber MA, Williams B, Yusuf S, Mann JF, Mahfoud F. Journal of Hypertension. 2021 Aug 1;39(8):1602-1610. doi: 10.1097/HJH.0000000000002822. PMID: 34188004

Cardiovascular system in the sars-CoV-2: impact of therapies. Redon J. Journal of Hypertension. 2021 Jul 1;39(7):1306-1308. doi: 10.1097/HJH.0000000000002860. PMID: 34074967

Cost of Type 2 diabetes patients with chronic kidney disease based on real-world data: an observational population-based study in Spain. Uso-Talamantes R, Gonzalez-de-Julian S, Diaz-Carnicero J, Sauri-Ferrer I, Trillo-Mata J, Carrasco-Perez M, Navarro-Perez J, Gorriz J, Vivas-Consuelo D, Redon J. International Journal of Environmental Research and Public Health. 2021 Sep 18;18(18):9853. doi: 10.3390/ijerph18189853. PMID: 34574782

Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes. Nunez-Gil I, Fernandez-Ortiz A, Maroud Eid C, Huang J, Romero R, Becerra-Munoz V, Uribarri A, Feltes G, Trabatoni D, Fernandez-Rozas I, Viana-Llamas M, Pepe M, Cerrato E, Bertaina M, Capel Astrua T, Alfonso E, Castro-Mejia A, Raposeiras-Roubin S, D’Ascenzo F, Espejo Paeres C, Signes-Costa J, Bardaji A, Fernandez-Perez C, Marin F, Fabregat-Andres O, Akin I, Estrada V, Macaya C. Cardiology Journal. 2021 Feb 11;42(6):700-710. doi: 10.1093/eurheartj/ehaa943. PMID: 33351892

Genetic variation and urine cadmium levels: ABCC1 effects in the Strong Heart Family Study. Grau-Perez M, Voruganti V, Balakrishnan P, Haack K, Goessler W, Franceschini N, Redon J, Cole S, Navas-Acien A, Tellez-Plaza M. Environmental pollution. 2021 Feb 11;276:116717. doi: 10.1016/j.envpol.2021.116717. PMID: 33640655

Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight. NCD Risk Factor Collaboration NCD. ELife. 2021 Mar 9;10:e60060. doi: 10.7554/eLife.60060. PMID: 33685583

Impact of obesity in kidney diseases. Kotsis V, Martinez F, Trakatelli C, Redon J. Nutrients. 2021 Dec 15;13(12):4482. doi: 10.3390/nu13124482. PMID: 34960033

Insights into glomerular filtration and albuminuria. Redon J, Selma-Soriano E, Cortes R. New England Journal of Medicine. 2021 Jul 29;385(5):477-478. doi: 10.1056/NEJMc2108129. PMID: 34320301

Prognostic value of diagnostic scales in community-acquired sepsis mortality at an emergency service. Prognosis in community-adquired sepsis. Clar J, Oltra MR, Benavent R, Pinto C, Ruiz A, Sanchez MT, Noceda J, Redon J, Forner MJ. BMC Emergency Medicine. 2021 Dec 18;21(1):161. doi: 10.1186/s12873-021-00532-1. PMID: 34922448

Rabphilin silencing causes dilated cardiomyopathy in a Drosophila model of nephrocyte damage. Selma-Soriano E, Casillas-Serra C, Artero R, Llamusi B, Navarro J, Redon J. Scientific Reports. 2021 Jul 27;11(1):15287. doi: 10.1038/s41598-021-94710-7. PMID: 34315987

Renal function and attributable risk of death and cardiovascular hospitalization in participants with diabetes from a registry-based cohort. Ruiz-Quintero M, Redón Mas J, Tellez-Plaza M, Cebrian-Cuenca A, Navarro Perez J, Menendez E, Perez-Navarro A, Fernandez-Gimenez A, Lopez-Pineda A, Quesada J, Pallares-Carratala V, Gil-Guillen V, Martín Moreno J, Bleda-Cano J, Carrascosa S, Carratala-Munuera C. Primary Care Diabetes. 2021 Feb;15(1):88-94. doi: 10.1016/j.pcd.2020.06.004. PMID: 32646765

Renal outcomes and blood pressure patterns in diabetic and nondiabetic individuals at high cardiovascular risk. Bohm M, Schumacher H, Teo K, Lonn E, Mahfoud F, Emrich I, Mancia G, Redon J, Schmieder R, Sliwa K, Lehrke M, Marx N, Weber M, Williams B, Yusuf S, Mann J. Journal of Hypertension. 2021 Apr 1;39(4):766-774. doi: 10.1097/HJH.0000000000002697. PMID: 33560052

SARS-CoV-2-reactive interferon-gamma-producing CD8+ T cells in patients hospitalized with Coronavirus Disease 2019. Gimenez Quiles E, Albert Vicent E, Torres Fink I, Remigia Pellicer M, Alcaráz Soriana M, Galindo Puerto M, Blasco Cortes M, Solano Vercet C, Forner Giner M, Redón Mas J, Signes-Costa Miñana J, Navarro Ortega D. Journal of Medical Virology. 2021 Jan;93(1):375-382. doi: 10.1002/jmv.26213. PMID: 32579268

Small Rab GTPases in intracellular vesicle trafficking: the case of Rab3A/Raphillin-3a complex in the kidney. Martinez-Arroyo O, Selma-Soriano E, Ortega A, Cortes R, Redon J. International Journal of Molecular Sciences. 2021 Jul 18;22(14):7679. doi: 10.3390/ijms22147679. PMID: 34299299

Supervised Analysis for Phenotype Identification: The Case of Heart Failure Ejection Fraction Class. Lopez C, Holgado JL, Cortes R, Sauri I, Fernandez A, Calderon JM, Nuñez J, Redon J. Bioengineering. 2021 Jun 21;8(6):85. doi: 10.3390/bioengineering8060085. PMID: 34205745

Therapeutic Potential of Extracellular Vesicles in Hypertension-Associated Kidney Disease. Martinez-Arroyo O, Ortega A, Redon J, Cortes R. Hypertension. 2021 Jan;77(1):28-38. doi: 10.1161/HYPERTENSIONAHA.120.16064. PMID: 33222549

Urinary exosomal miR-146a as a marker of albuminuria, activity changes and disease flares in lupus nephritis. Perez Hernandez J, Martínez Arroyo O, Ortega Gutiérrez A, Galera Martos M, Solis Salguero M, Chaves Martínez F, Redón Mas J, Forner Giner M, Cortés Vergaz R. Journal Of Nephrology. 2021 Aug;34(4):1157-1167. doi: 10.1007/s40620-020-00832-y. PMID: 32803682

Urinary- and Plasma-Derived Exosomes Reveal a Distinct MicroRNA Signature Associated With Albuminuria in Hypertension. Perez-Hernandez J, Riffo-Campos A, Ortega A, Martinez-Arroyo O, Perez-Gil D, Olivares D, Solaz E, Martinez F, Martinez-Hervas S, Chaves F, Redon J, Cortes R. Hypertension. 2021 Mar 3;77(3):960-971. doi: 10.1161/HYPERTENSIONAHA.120.16598. PMID: 33486986

Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. NCD Risk Factor Collaboration. Lancet. 2021 Sep 11;398(10304):957-980. doi: 10.1016/S0140-6736(21)01330-1. PMID: 34450083

Projects
Reference: 101083002- INNDIH
Title: 101083002- INNDIH – Valencia Region Digital Innovation Hub
Funding body: European Commission
Principal Investigator: Josep Redón i Mas
Duration: 2023 – 2025
Total budget: 225.395,50 €
Reference: 101095480- Hypermarker
Title: Personalised pharmacometabolomic optimisation of treatment for hypertension
Funding body: European Commission
Principal Investigator: Josep Redón i Mas
Duration: 2023 – 2026
Total budget: 400.000 €
Reference: INTEGRA-CLOUD
Title: Creación de una plataforma abierta de acceso, captura, almacenamiento e intercambio descentralizado de los datos de salud en tiempo real del Departamento de Salud Clínico-Malvarrosa para la computación cloud-edge de sistemas predictivos, de toma de decisiones y de inteligencia artificial
Funding body: Ministerio de Asuntos Económicos y Transformación Digital
Principal Investigator: Josep Redón i Mas
Duration: 2023 – 2025
Total budget: 5.252.274 €
Reference: EHDEN – OMOP
Title: EHDEN. Harmonization Fund Holder
Funding body: European Commission (3rd Health Program)
Principal Investigator: Josep Redón i Mas
Duration: 2022 – 2023
Total budget: 50.000,00 €
Reference: 945097-WELLBASED
Title: WELLBASED. Improving health, wellbeing and equality by evidenced-based urban policies for tackling energy poverty
Funding body: European Commission
Principal Investigator: Josep Redón i Mas
Duration: 2021 – 2025
Total budget: 395.250,00 €
Reference: PI19/01796
Title: Implicaciones experimentales y clinicas del complejo proteico rabphilin-rab en daño renal en la diabetes mellitus tipo 2
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Josep Redón i Mas
Duration: 2020 – 2023
Total budget: 196.020 €
Reference: 780495-BigMedilytics
Title: Big Data for Medical Analytics
Funding body: European Commission
Principal Investigator: Josep Redón i Mas
Duration: 2018 – 2021
Total budget: 1.062.136 €
Reference: PT17/0005/0017
Title: Plataforma de Innovación
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Josep Redón i Mas
Duration: 2018 – 2021
Total budget: 38.985 €
Reference: BodyPass
Title: API-ecosystem for cross-sectorial exchange of 3D personal data
Funding body: European Commission
Principal Investigator: Josep Redón i Mas
Duration: 2018 – 2021
Total budget: 351937,5
Reference: PI16/01402
Title: Estudio experimental in vivo e in vitro y la aplicación clínica del impacto de las proteínas del complejo Rhabphilin-Rab en el desarrollo del daño renal y cardiovascular
Funding body: Instituto de Salud Carlos III – Cofinanciado FEDER
Principal Investigator: Josep Redón i Mas
Duration: 2017 – 2019
Total budget: 194.205 €
Reference: BigData@Heart
Title: Big Data for Better Hearts
Funding body: European Commission
Principal Investigator: Josep Redón i Mas
Duration: 2017 – 2022
Total budget: 386250
Reference: ADVANTAGE
Title: Managing Frailty. A comprehensive approach to promote a disability-free advanced age in Europe: the ADVANTAGE initiative
Funding body: European Commission (3rd Health Program)
Principal Investigator: Josep Redón i Mas, José Viña Ribes
Duration: 2016 – 2019
Total budget: 130.005 €
Reference: PROMETEO/2016/084
Title: Innovación tecnológica en la evaluación del sistema nervioso simpático en adolescentes y adultos jóvenes obesos: papel en la estratificación del riesgo e intervención terapéutica
Funding body: Conselleria de Educación, Cultura y Deporte
Principal Investigator: Josep Redón i Mas
Duration: 2016 – 2019
Total budget: 246.190 €
+ Info
2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). Mancia Chairperson G, Kreutz Co-Chair R, Brunstrom M, Burnier M, Grassi G, Januszewicz A, Muiesan M, Tsioufis K, Agabiti-Rosei E, Algharably E, Azizi M, Benetos A, Borghi C, Hitij J, Cifkova R, Coca A, Cornelissen V, Cruickshank K, Cunha P, Danser A, de Pinho R, Delles C, Dominiczak A, Dorobantu M, Doumas M, Fernandez-Alfonso M, Halimi J, Jarai Z, Jelakovic B, Jordan J, Kuznetsova T, Laurent S, Lovic D, Lurbe E, Mahfoud F, Manolis A, Miglinas M, Narkiewicz K, Niiranen T, Palatini P, Parati G, Pathak A, Persu A, Polonia J, Redon J, Sarafidis P, Schmieder R, Spronck B, Stabouli S, Stergiou G, Taddei S, Thomopoulos C, Tomaszewski M, Van de Borne P, Wanner C, Weber T, Williams B, Zhang Z, Kjeldsen S. Journal of Hypertension. 2023 Dec 1;41(12):1874-2071. doi: 10.1097/HJH.0000000000003480. PMID: 37345492

2022 Practice guidelines for the management of arterial hypertension of the Spanish Society of Hypertension. Gorostidi M, Gijón-Conde T, de la Sierra A, Rodilla E, Rubio E, Vinyoles E, Oliveras A, Santamaría R, Segura J, Molinero A, Pérez-Manchón D, Abad M, Abellán J, Armario P, Banegas JR, Camafort M, Catalina C, Coca A, Divisón JA, Domenech M, Martell N, Martín-Rioboó E, Morales-Olivas F, Pallarés V, Pérez de Isla L, Prieto MA, Redón J, Ruilope LM, García-Donaire JA. Hipertensión y Riesgo Vascular. 2022 Oct-Dec;39(4):174-194. doi: 10.1016/j.hipert.2022.09.002. PMID: 36153303

Redefining hypertension in children and adolescents: A review of the evidence considered by the European Society of Hypertension and American Academy of Pediatrics guidelines.Stabouli S, Redón Mas J, Lurbe Ferrer E. Journal of Hypertension. 2020 Feb;38(2):196-200. doi: 10.1097/HJH.0000000000002247. PMID: 31584513

2018 ESC/ESH Guidelines for the management of arterial. Williams B, Mancia G, Spiering W, Rosei EA, Azizi M, Burnier M, Clement DL, Coca A, de Simone G, Dominiczak A, Kahan T, Mahfoud F, Redon J, Ruilope L, Zanchetti A, Kerins M, Kjeldsen SE, Kreutz R, Laurent S, Lip GYH, McManus R, Narkiewicz K, Ruschitzka F, Schmieder RE, Shlyakhto E, Tsioufis C, Aboyans V, Desormais I. Kardiologia Polska. 2019;77(2):71-159. doi: 10.5603/KP.2019.0018. PMID: 30816983

Impact of ESH and AAP hypertension guidelines for children and adolescents on office and ambulatory blood pressure-based classifications. Lurbe E, Torró I, Álvarez J, Aguilar F, Mancia G, Redon J, Redon P. Journal of Hypertension. 2019 Dec;37(12):2414-2421. doi: 10.1097/HJH.0000000000002229. PMID: 31688292

Title: Evaluación cardiometabólica y adrenérgica en el sujeto obeso sano joven
Doctoral candidate: Ruiz Hernández, Adrián
Director(s): Forner Giner, Mª José; Redón i Mas, Josep
Date of the defense: 28/04/2022
University: Universitat de València

Title: Monitorización del manejo de sepsis para la identificación de flujos asistenciales y su impacto en la evolución de los pacientes. El diagnóstico precoz de sepsis en urgencias
Doctoral candidate: Clar Bononad, Jorge
Director(s): Oltra Sempere, Mª Rosa; Redón i Mas, Josep
Date of the defense: 10/02/2022
University: Universitat de València

Title: Valor pronóstico de los cambios en la rigidez arterial en la hipertensión arterial esencial
Doctoral candidate: Calaforra Juan, Oscar
Director(s): Redón Mas, Josep; Forner Giner, María José; Martínez García, Fernando
Date of the defense: 28/07/2020
University: Universitat de València

Title: Sistema de biosensado fotónico para la detección de trombina, alérgenos y patógenos. Funcionalización química de chips fotónicos basados en estructuras de anillos resonantes
Doctoral candidate: Sánchez Sánchez, Carlos
Director(s): Martí Sendra, Javier; Redón Mas, Josep; Peransí Llopis, Sergio Manuel
Date of the defense: 15/11/2019
University: Universitat Politècnica de València

Title: Estudio de la evolución del sellado distal ilíaco en el tratamiento endovascular de la aorta abdominal
Doctoral candidate: Bargay Juan, Pau
Director(s): Redon Mas, Josep; Plaza Martínez, Ángel
Date of the defense: 25/02/2019
University: Universitat de València